Evidence map›Paper›PMID 37251808›Full record

ReviewFrontiers in aging neuroscience2023

Biomarkers of delirium risk in older adults: a systematic review and meta-analysis.

Lucía Lozano-Vicario, Antonio García-Hermoso, Bernardo Abel Cedeno-Veloz, Joaquín Fernández-Irigoyen, Enrique Santamaría, Román Romero-Ortuno, Fabricio Zambom-Ferraresi, Mikel L Sáez de Asteasu, Ángel Javier Muñoz-Vázquez, Mikel Izquierdo and 1 more

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in aging neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06509191 (Effect of Melatonin Versus Placebo for Prevention of Delirium Among Medically Hospitalized Patients), which is not on this map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06509191 phase2 / phase3recruitingnot on this mapstarted 2024, after this paper: background citation

Effect of Melatonin Versus Placebo for Prevention of Delirium Among Medically Hospitalized Patients: Study Protocol for a Single-Center, Double-Blinded, Randomised Controlled Trial

TypeinterventionalSponsorSultan Qaboos UniversityRan2024 to 2025Enrolled240ConditionsDeliriumArmsIntervention 1, Intervention 2, Control
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Lucía Lozano-VicarioGeriatric Unit, Hospital Universitario de Navarra (HUN), Pamplona, Spain.
Antonio García-HermosoNavarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
Bernardo Abel Cedeno-VelozGeriatric Unit, Hospital Universitario de Navarra (HUN), Pamplona, Spain.
Joaquín Fernández-IrigoyenProteomics Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain.
Enrique SantamaríaProteomics Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain.
Román Romero-OrtunoGlobal Brain Health Institute, Trinity College Dublin, Dublin, Ireland.
Fabricio Zambom-FerraresiNavarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
Mikel L Sáez de AsteasuNavarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
Ángel Javier Muñoz-VázquezOrthopaedic Surgery and Traumatology Department, Clínica Universidad de Navarra, Pamplona, Spain.
Mikel IzquierdoNavarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
Nicolás Martínez-VelillaGeriatric Unit, Hospital Universitario de Navarra (HUN), Pamplona, Spain.
Universidad Publica de Navarra · ESNavarre Institute of Health Research · ESUniversidad de Navarra · ESClinica Universidad de Navarra · ESNavarrabiomed · ESTrinity College Dublin · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Delirium is a neuropsychiatric syndrome associated with increased morbidity and mortality in older patients. The aim of this study was to review predictive biomarkers of delirium in older patients to gain insights into the pathophysiology of this syndrome and provide guidance for future studies. Two authors independently and systematically searched MEDLINE, Embase, Cochrane Library, Web of Science and Scopus databases up to August 2021. A total of 32 studies were included. Only 6 studies were eligible for the meta-analysis, pooled results showed a significant increase in some serum biomarkers (C-reactive protein [CRP], tumour necrosis factor alpha [TNF-α] and interleukin-6 [IL-6]) among patients with delirium (odds ratio = 1.88, 95% CI 1.01 to 1.637; I2 = 76.75%). Although current evidence does not favour the use of any particular biomarker, serum CRP, TNF-

Indexed as

biomarkerscognitive impairmentdeliriumneuroinflammationolder people

Identifiers

PMID37251808
PMCPMC10213257
OpenAlexW4378744992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.